Researchers at the Indian Institute of Technology–Madras have developed a patented, minimally invasive continuous glucose ...

On Friday, Senseonics, maker of the implantable continuous glucose monitoring system Eversense, announced a new program geared towards patients with high-deductible insurance plans or plans that don’t ...

Sequel and Senseonics are teaming up on a development agreement aimed at transforming diabetes care. The collaboration will involve the integration of Sequel’s twiist Automated Insulin Delivery (AID) ...

The global patient monitoring devices market size is expected to reach USD 118.21 billion by 2033, registering a CAGR of 10.21% from 2025 to 2033, according to a new report by Grand View Research, Inc ...

Trinity Biotech plc has announced encouraging results from its recent pre-pivotal clinical trial of its next-generation continuous glucose monitoring (CGM) system, targeting diabetes management. The ...